Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAYLOR RESEARCH INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Alirocumab in Patients on a Stable Dialysis Regimen

Phase 3

Conditions: Hemodialysis
Hypercholesterolemia
Peritoneal Dialysis
Atherosclerotic Disease

Interventions: Drug: Alirocumab 150 MG/ML [Praluent]

First Posted Date: 2018-03-29

Last Posted Date: 2020-02-12

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 20

Registration Number: NCT03480568

Locations: 🇺🇸
Baylor Soltero CV Research, Dallas, Texas, United States

Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer

Not Applicable

Completed

Conditions: Triple Negative Breast Cancer

Interventions: Dietary Supplement: Glucose

First Posted Date: 2018-03-08

Last Posted Date: 2021-10-08

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 16

Registration Number: NCT03457779

Locations: 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients

Not Applicable

Completed

Conditions: Sepsis
Nutrition Disorders
Critical Illness
Calorie Deficiency
Diaphragm Injury
Respiratory Failure
Quadriceps Muscle Atrophy

Interventions: Other: Caloric delivery will target results of IC measurement.

First Posted Date: 2018-02-22

Last Posted Date: 2020-10-22

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 25

Registration Number: NCT03440593

Locations: 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Harmonica Playing Improves Quality of Life in Patients With COPD

Not Applicable

Completed

Conditions: COPD

Interventions: Other: Harmonica playing

First Posted Date: 2018-02-22

Last Posted Date: 2020-05-19

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 15

Registration Number: NCT03442140

Locations: 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Exploration and Determination of Genomic Markers Predictive of Uterine Atony

Conditions: Uterine Atony

Interventions: Other: Analysis of genomic markers in uterine atony

First Posted Date: 2018-01-29

Last Posted Date: 2018-07-17

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 20

Registration Number: NCT03413917

Locations: 🇺🇸
Baylor Univeristy Medical Center, Dallas, Texas, United States

Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

Terminated

Conditions: Glioblastoma

Interventions: Device: Optune

First Posted Date: 2018-01-19

Last Posted Date: 2019-03-27

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 10

Registration Number: NCT03403803

Locations: 🇺🇸
Baylor Scott and White Medical Center, Temple, Texas, United States

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

Phase 2

Conditions: Heart Failure

Interventions: Drug: Epclusa

First Posted Date: 2017-12-26

Last Posted Date: 2023-01-26

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 15

Registration Number: NCT03383419

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms

Withdrawn

Conditions: Gastric Emptying
Sleeve Gastrectomy
Weight Loss
Bariatric Surgery Candidate
Diabetic Gastroparesis

First Posted Date: 2017-12-18

Last Posted Date: 2020-07-02

Lead Sponsor: Baylor Research Institute

Registration Number: NCT03376399

Locations: 🇺🇸
Baylor Weight Loss Surgery Center, Dallas, Texas, United States

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

Phase 2

Active, not recruiting

Conditions: Compliance, Patient
Graft Failure
Heart Transplant Rejection

Interventions: Drug: Envarsus

First Posted Date: 2017-12-14

Last Posted Date: 2023-01-26

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 50

Registration Number: NCT03373227

Locations: 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities

Active, not recruiting

Conditions: Heart Transplant Failure and Rejection

First Posted Date: 2017-12-14

Last Posted Date: 2023-01-26

Lead Sponsor: Baylor Research Institute

Target Recruit Count: 69

Registration Number: NCT03373279

Locations: 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy